Pfizer today announced the launch of a new research unit known as Pfizer Regenerative Medicine. 18 Nov 2008
Results from clinical trials show promise for innovative therapies in rheumatoid arthritis and osteoarthritis pain and fibromyalgia. 11 Nov 2008
A major consumer group in the US has asked the Food and Drug Administration to ban the diabetes drug rosiglitazone. 9 Nov 2008
MabThera continues to improve patient response in rheumatoid arthritis with
multiple courses of treatment. MabThera shown to be effective and well tolerated over the long-term. 30 Oct 2008
Action involves Bayer Aspirin with Heart Advantage and Bayer Women's Low Dose Aspirin + Calcium. 29 Oct 2008
European authorities have recommended that the anti-obesity drug, rimonabant, is not prescribed. 27 Oct 2008
AstraZeneca and Nomura Phase4 Ventures announce creation
of new company “Albireo” 20 Oct 2008
“The worst pain one can possibly imagine”. 18 Oct 2008
With the Christmas season fast approaching, holiday plans are now being made. 18 Oct 2008
Thousands of South Africans are busy preparing to undertake the annual pilgrimage to Mecca. 14 Oct 2008
Phase 3 Cohort now Includes 25 Programmes; additions in key disease areas including cancer and heart disease. 8 Oct 2008
Dutch pharmaceutical packager Tjoapack implements a marking and coding system that exceeds existing global requirements for track and trace. 3 Oct 2008
Since the first approval of a targeted therapy for cancer just over ten years ago, targeted therapies have notably improved treatment outcomes in cancer, becoming the leading therapy class in the oncology market. 3 Oct 2008
AstraZeneca has taken a step forward in safeguarding patient wellbeing with the introduction of a Tamper Evident Security Seal (TESS) on the packaging of its antibiotic, Meronem® (meropenem trihydrate). 20 Sep 2008
JSE listed Aspen Pharmacare Holdings Limited, Africa's largest pharmaceutical manufacturer, is pleased to announce positive results for the year ended 30 June 2008. 16 Sep 2008
South Africa leads continent in bringing benefits of routine vaccination against Pneumococcal disease to infants and young children. 14 Sep 2008
Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? 11 Sep 2008
US regulators are calling for stronger label warnings on tumour necrosis factor-alpha drugs as they increase the risk of fungal infections. 10 Sep 2008
Sophisticated replication techniques have made counterfeiting and fraud a serious threat to the pharmaceutical and medical industry—and to the suppliers to the sector, like packaging companies. 9 Sep 2008
With the costs of providing healthcare spiralling, governments and payers across the seven major markets are implementing cost-cutting initiatives in an effort to combat these escalating healthcare costs, which in turn is putting even greater pressure on pharma companies. 4 Sep 2008
Let's do Biz